Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment

BMC Endocrine Disorders
Tao TaoW Liu

Abstract

Impaired insulin activity in women with polycystic ovary syndrome might differ from that seen in type 2 diabetes mellitus without polycystic ovary syndrome. This study was designed to compare the effects of treatment with metformin, saxagliptin, and their combination in newly diagnosed women with type 2 diabetes mellitus and polycystic ovary syndrome in China. A total of 75 newly diagnosed patients from Shanghai, China with type 2 diabetes mellitus and polycystic ovary syndrome were included in this randomized, parallel, open-label study. All patients received treatment for 24 weeks with metformin, saxagliptin, or their combination. Patients were allocated to one of three treatment groups by a computer-generated code that facilitated equal patient distribution of 25 patients per group. The primary outcome was a change in glycemic control and β-cell function. A total of 63 patients completed the study (n = 21, for each group). The reduction in hemoglobin A1c was significant in the combination group, compared to the monotherapy groups (saxagliptin vs. combination treatment vs. metformin: - 1.1 vs. -1.3 vs. -1.1%, P = 0.016), whereas it was comparable between the metformin and saxagliptin groups (P > 0.05). Saxagliptin, metformin,...Continue Reading

References

Oct 28, 2004·The Journal of Clinical Endocrinology and Metabolism·David A EhrmannUNKNOWN PCOS/Troglitazone Study Group
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
Sep 13, 2007·Journal of Endocrinological Investigation·G CrepaldiG Paolisso
Oct 12, 2007·Physiological Reviews·Jens Juul Holst
Jan 4, 2008·The New England Journal of Medicine·John E Nestler
May 31, 2008·European Journal of Endocrinology·Jana VrbikovaGiovanni Pacini
Oct 21, 2009·European Journal of Endocrinology·Evanthia Diamanti-KandarakisFrangiskos N Economou
Jun 16, 2011·Journal of Women's Health·Charalambos PontikisJohn G Yovos
Sep 5, 2012·Nature Reviews. Endocrinology·Juris J Meier
Mar 15, 2016·Best Practice & Research. Clinical Obstetrics & Gynaecology·Sunita M C De Sousa, Robert J Norman

❮ Previous
Next ❯

Citations

Aug 23, 2020·International Journal of Molecular Sciences·Angela DziedzicMichal Bijak
Dec 19, 2020·International Journal of Molecular Sciences·Andrea CignarellaCarla Scaroni
Feb 9, 2021·Therapeutic Advances in Endocrinology and Metabolism·Mohammed Altigani AbdallaThozhukat Sathyapalan

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.